MAIDENHEAD, England, July 7 /PRNewswire/ --

- First-in-Class Treatment set to Provide a New and Important Targeted Treatment for Distressing and near Universal Side Effect in Patients Receiving Opioids for Pain Relief as Part of Palliative Care

Wyeth Pharmaceuticals, today 3rd July, announced that it has received EMEA marketing approval for Relistor(TM) (methylnaltrexone bromide) subcutaneous injection. This first-in-class treatment is indicated for opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to the usual laxative therapy has not been sufficient.

PARIS, July 7 /PRNewswire/ -- Valeo announced today that it has signed a contract with PSA Peugeot Citroen to equip more than one million vehicles with its Stop-Start technology by 2011.

"This is an important contract," declared Thierry Morin, Valeo Chairman & CEO. "The confidence expressed by the PSA Group through this contract shows that our strategy is supported by automakers. Our objective is to develop, as of today, affordable solutions accessible to the greatest number of motorists."

BALTIMORE, July 7 /PRNewswire/ --

Physicians Practice, America's Leading Practice Management Journal today announced the promotions of Pamela L. Moore, Ph.D to editorial director, Steven Gottshall to associate publisher, and Eric Temple-Morris to associate publisher. The promotions are reflective of the company's overall strategy for the continued growth of brand awareness, expansion into new physician focused markets and circulation growth.

HONG KONG, July 7 /PRNewswire/ --

OrbusNeich today announced that data presented recently at the 17th Annual Meeting of the Japanese Society of Interventional Cardiology demonstrate that the Genous Bio-engineered R stent has better outcomes when compared to drug-eluting stents.

Presented by Federico Piscione, M.D., the study's principal investigator and a professor with the Federico II University of Naples's Division of Cardiology, Department of Clinical Medicine and Cardiovascular Sciences, the data were generated following a study that involved 257 consecutive high-risk patients who underwent percutaneous coronary intervention with either the Genous stent or a TAXUS(R) and CYPHER(R) stent at the university's catheterization lab.

REDMOND, Washington, July 7 /PRNewswire/ --

Microsoft Corp. today issued the following statement:

In the past week we have had the opportunity to discuss with Carl Icahn the prospects for a possible agreement between Microsoft and Yahoo!.

MILPITAS, California, July 7 /PRNewswire/ --

- UK Service Provider Taps JDSU Service Assurance Solutions to Support Wide-scale Deployment of Next Generation Network and Advanced IP/Broadband Services

JDSU today announced it has entered into a contract to provide service assurance test solutions to The Carphone Warehouse Networks (CPWN), one of the largest and most advanced telecom networks in the UK, and a wholly-owned division of the fixed line and broadband business of The Carphone Warehouse (CPW) Group plc. The JDSU service assurance system, NetComplete, will support the design, implementation and management of the Next Generation Network (NGN) for CPWN, covering both its residential and business customers via local loop unbundling.

CALGARY, Canada, July 7 /PRNewswire/ --

- 200 Million Barrels Produced From OML 123 Offshore Nigeria

Addax Petroleum Corporation (TSX: AXC and LSE: AXC) ("Addax Petroleum" or the "Corporation") announces today that the historic milestone of 200 million barrels of oil production from the Addax Petroleum operated Oil Mining Lease ("OML") 123 offshore Nigeria has been achieved. OML123, the Corporation's first Nigerian license and largest license by production and reserves volumes, is located in the shallow water offshore in the Niger Delta Basin, one of the most prolific petroleum basins in the world.

BARCELONA, July 7 /PRNewswire/ -- The winners of the Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) are announced today at the European Society for Human Reproduction & Embryology Congress. The two winners of this new prize are the University Medical Centre Utrecht, The Netherlands and the Universitair Ziekenhuis (UZ) Brussel, Centre for Reproductive Medicine,Belgium.

The winning research institutions were selected for their outstanding proposals for fundamental research to help gain an increased understanding of the role of human chorionic gonadotrophin (hCG) in assisted reproduction.

SOUTHAMPTON, England, July 7 /PRNewswire/ --

- First of a new generation of capacitive touch sense ICs

Atmel(C) Corporation (Nasdaq: ATML) announced today the AT42QT2160 -- a touch controller IC combining touch key and touch slider functions in a single device. The AT42QT2160 can control up to 16 individual touch keys with a slider comprising between 2 and 8 of the touch key channels. In addition, the chip can also control up to 11 LEDs through a PWM output function that is controlled by the host, eliminating the need for an external LED controller.

LONDON, July 7 /PRNewswire/ --

ICE Clear Europe(TM), a wholly-owned subsidiary of IntercontinentalExchange (NYSE: ICE), today announced that it has reached consensus with LCH.Clearnet (LCH) on the technical issues to facilitate the movement of all ICE Futures Europe(TM) and ICE over-the-counter (OTC) trading positions from LCH to ICE Clear Europe. Under the technical framework, ICE expects the transition of clearing to ICE Clear Europe to occur during the month of August, with a specific transition date to be finalized in the coming days following consultation with clearing members.

The existing futures and OTC clearing arrangements between ICE and LCH will remain in effect until the transition is complete.